US Patent 7094768 Nucleoside derivatives for treating hepatitis C virus infection
Patent 7094768 was granted and assigned to Genelabs Technologies on August, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Christopher D. Roberts0
Jesse Keicher0
Natalia B. Dyatkina0
Edits on 29 Aug, 2023
Golden AI
Edits made to:
Article (+262 characters)
Article
Patent abstract
Disclosed are 6-hydroxyamino- or a 6-alkoxyamino-7-deazapurine-ribofuranose derivatives, salts, pharmaceutical compositions, and methods of use thereof for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07094768 Nucleoside derivatives for treating hepatitis C virus infection US Patent 7094768 Nucleoside derivatives for treating hepatitis C virus infection
Infobox
Patent Number
07094768
Patent Number
7094768
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 16 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07094768 Nucleoside derivatives for treating hepatitis C virus infection
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07094768
Date of patent
August 22, 2006
Patent application number
10821638
Date Filed
April 8, 2004
Patent primary examiner
Find more entities like US Patent 7094768 Nucleoside derivatives for treating hepatitis C virus infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
